CYL-02

N/A

Report date: 2024/12/23 11:16:34

Base Information

Drug NameCYL-02
Drug Alias NameCYL-02 + gemcitabineCYL-02
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionEnzyme induced prodrug activatorsGene transference
TargetsNot applicable
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInvivogen Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesInvivogen Therapeutics
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A